The Safety and Efficacy of Electronic Moxibustion for Dry Eye: An Investigator-initiated, Assessor-blinded, Randomized Controlled Parallel Trial

aju Dongshin University Korean Medicine Hospital0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月2日

适应症

试验速览

暂无简介。

•Participants should satisfy all following criteria;
•1. Male and female patients aged 19-65 at the screening visit.
•2. Patients who have typical dry eye symptoms including pruritus, foreign body sensation, pain, dryness, blurry eye, dazzle, eye congestion, and illacrimation.
•3. Patients who are diagnosed dry eye syndrome by more than 13 score in the Ocular Surface Disease Index.
•4. Patients who submitted written consent voluntarily.

•Patients who satisfy any criterion of the followings cannot participate in this study;
•1. Dry eye syndrome caused by eyelid or eyelashes problems.
•2. Irritated eye caused by acute inflammation arose from eyelid, eyeball, or ocular adnexa.
•3. Diagnosed as skin diseases including Stevens-Johnson syndrome, pemphigoid, or etc.
•4. Diagnosed as vitamin A deficiency.
•5. Patients who have damages caused by injury of eyeball or ocular adnexa.
•6. Patients who had operation to anterior segment of the eye or operation via anterior eye including cataract or LASIK within recent 3 months.
•7. Have a difficulty in blink because of facial palsy.
•8. Received punctal plug or punctal occlusion.
•9. Used anti-inflammatory drops including cyclosporine, corticosteroids, or autoserotherapy directly to the eye within recent 2 weeks.
•10. Administering systemic corticosteroids or immunosuppressants.
•11. Pregnant, lactating women, or women planning pregnancy.
•12. Other cases which investigators determined inadequate.

发起方

aju Dongshin University Korean Medicine Hospital